| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 77810 | Naphtho[1,2-b]quinolizinium, 9-methyl-, bromide | 0.0123744972338279 | 0.11696311 |
| NSC 112152 | 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) | 0.012374497233828 | -0.14604231 |
| NSC 633203 | Null | 0.0123744972338281 | -0.1640907 |
| NSC 762934 | Null | 0.0123744972338281 | -0.27547902 |
| NSC 107124 | Camptothecin Derivative | 0.0140755620492158 | -0.019509455 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0140755620492158 | 0.32180237 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0140755620492158 | 0.35113863 |
| NSC 236580 | .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone | 0.0140755620492158 | 0.27780844 |
| NSC 305799 | 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- | 0.0140755620492158 | 0.33677535 |
| NSC 644221 | Null | 0.0140755620492158 | 0.1883786 |